Almac invests in two ZED automated inline wallet presses

NewsGuard 100/100 Score

Global Clinical Services provider Almac has announced an investment in two ZED automated inline wallet presses. Operating in Craigavon and Pennsylvania, the fully automated machines will drastically reduce timelines associated with the use of blister card packaging, when compared with current rotary press methods.

The automation on the machine allows for accurate placement of blister strips into the wallet cards. The location and orientation of the blisters is then verified by a vision system prior to sealing the card. This helps to keep rejects to a minimum and maximises yield on product. This is the latest development in an ongoing campaign by Almac to continually invest in automation as a boost in efficiency and capacity to core primary packaging services.

Commenting on the new machines, Almac's Global VP of Business Development Martin Lamb said "The machines are a welcomed addition to Almac's growing portfolio of automated primary packaging services as they demonstrate the company's continued commitment to innovation and driving improvements across the clinical supply chain. These lines are ideal for larger Phase III trials that can require higher volumes of wallet cards. Also product pooling and using supplies across multiple protocols can drive card quantities past the traditional smaller volumes required for clinical supply. This allows us to provide the client with the right option for their study."

The investment comes at a time when Almac is gearing up for the official opening of their New North American Headquarters facility. The $120 million project, which began in Summer 2008 is now operational with the official opening of the 240,000 square foot premises planned for May 2011.

With over 20 years experience in clinical supply management (http://www.almacgroup.com/clinicalservices/clinical-supply-management.aspx) Almac is recognised as a strategic partner in the clinical supply process by pharma and biotech companies across the world. These recent investments are a sign of their dedication to offer market driven solutions to their customers.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
The MagBinder® Fit24 nucleic acid purification system